Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: SCANTOX NEURO GMBH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-30 to 2025-09-29
Current total value of award: $249000
Description: TOLERABILITY STUDIES OF CANDIDATE AD DRUGS AND EFFICACY OF POLY(L-LYSINE SUCCINYLATED)-HYDROXYCHLOROQUINE (PLS-HCQ) IN A TRANSGENIC AD MOUSE MODEL